Philadelphia Drug Exchange
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2011 | 38,860 | 56,766 | −17,906 | 1.4 | — |
| 2013 | 40,749 | 38,360 | 2,389 | 2.5 | — |
| 2014 | 55,019 | 32,333 | 22,686 | 11.4 | — |
| 2016 | 49,016 | 38,724 | 10,292 | 14.4 | — |
| 2017 | 40,947 | 36,955 | 3,992 | 16.4 | — |
| 2018 | 17,130 | 26,792 | −9,662 | 18.3 | — |
| 2019 | 41,891 | 53,436 | −11,545 | 6.6 | — |
| 2020 | 18,107 | 32,424 | −14,317 | 5.5 | — |
| 2022 | 33,544 | 31,338 | 2,206 | 3.7 | — |
In its most recent public year (2022), this organization brought in $2,206 more than it spent. Its reserves stood at about 3.7 months of spending, up from 1.4 in 2011.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2022. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
Philadelphia Drug Exchange's IRS filings as a feed — one entry per filing year, through 2022. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works